Semanize 4 mg (Semaglutide)
| Active Ingredient | Semaglutide |
|---|---|
| Indication: | Type 2 diabetes |
| Manufacturer: | Bionize Pharmatech Ltd. |
| Packaging | 1 pen in box |
| Strength | 4mg |
| Delivery Time | 6 To 15 days |
Semanize 4 mg (Semaglutide) is a GLP-1 (glucagon-like peptide-1) receptor agonist used in the treatment of type 2 diabetes mellitus and weight loss therapy. It is administered via once-weekly injection, offering both convenience and powerful glucose-lowering effects.
Semaglutide mimics the action of the natural incretin hormone GLP-1, which:
Stimulates insulin release when blood sugar is high
Reduces glucagon secretion (a hormone that raises blood sugar)
Slows gastric emptying, leading to reduced appetite and calorie intake








There are no reviews yet.